First-in-human Phase 1 Study of Pimicotinib (ABSK021), a CSF-1R Inhibitor, in Patients with Advanced Solid Tumors.Gerald Steven Falchook,Yan Liang,R. Donald Harvey,Siqing Fu,Yao Weitao,Yan-Ru Qin,Xiaojing Zhang,Jason Timothy Henry,Qingping Zou, Boyao Shan,Pan Liang,Chen Wang, Wenjia Li, Zehra Nurgul Pamuklar,Yi Pei,Zhiwei Chang,Jiaqiang Wang,Sarina A. Piha-Paul,Manali A. Bhave,Yongmei YinJOURNAL OF CLINICAL ONCOLOGY(2023)引用 0|浏览0暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要